Ketamine for Depression—Knowns, Unknowns, Possibilities, Barriers, and Opportunities
JAMA Psychiatry December 1, 2023 DOI: 10.1001/jamapsychiatry.2023.3982
Summary
AI-generated from the abstractKetamine, an anesthetic with a history of recreational use, is being investigated for new on- and off-label indications across medical disciplines, including treatment-resistant depression, chronic pain, and other conditions. The article discusses the expanding experimental and clinical applications of ketamine, highlighting its potential benefits and risks as research progresses.
Study at a glance
| Characteristics | Review Peer reviewed |
|---|---|
| Intervention | Ketamine |
| Key finding | Ketamine is being investigated for new on- and off-label indications across multiple medical disciplines. |
Abstract
This Viewpoint discusses ketamine and its new and experimentally investigated on- and off-label indications that span different medical disciplines.